00173-0896 Blenrep - CanMED: NDC

Product NDC:

00173-0896

Brand Name:

Blenrep

Generic Name:

Belantamab

Dosage Form Name:

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Administration Route:

Intravenous

Substances:

Name: BELANTAMAB MAFODOTIN

Strength: 50.0

Unit: mg/mL

Packages:

Code: 00173-0896-01

Description: 1 VIAL in 1 CARTON (0173-0896-01) / 2 mL in 1 VIAL

Effective Date: Aug. 5, 2020

Discontinued: June 30, 2024

SEER*Rx Category:

Immunotherapy

Major Class:

Drug Antibody Conjugate

Minor Class:

BCMA

Orphan Drug Designation:

Status:

No Longer Used

CanMED and the Oncology Toolbox